Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
6th grade Avg
|
New words:
ability, accrual, adequacy, adjacent, agenda, aiding, apprise, asthma, audit, back, bad, begun, BI, Boehringer, British, broader, buy, calendar, cancelled, care, certify, certifying, Chief, children, coli, commentary, committee, comparison, concluded, Confidential, confidentiality, conform, corrective, CRL, database, defined, depreciable, deviate, disclosed, disclosure, doubtful, duration, efficacy, encounter, England, ensure, equipment, equivalent, exhibit, exhibited, extraordinary, fairly, flow, fourth, fraud, fundamental, health, HITT, hMPV, hopeful, immunogenicity, infrastructure, Ingleheim, Insert, intrinsic, issuer, judged, knowledge, laboratory, lawsuit, length, light, Lota, magnitude, misleading, mos, motion, movement, observed, omit, opportunity, outsourcing, Package, page, participation, pipeline, preclinical, preliminary, prepared, preparing, printed, proceed, profile, proration, psoriatic, recovery, regularly, removal, representation, retreatment, return, role, rolling, ruled, scrutiny, set, settlement, shift, short, side, Siplizumab, sooner, spectrum, Supplementary, syncytial, tentative, tolerated, tracking, transmission, treatment, untrue, veto, ViroNovative, VRBPAC, wheezing, wholly, young, Zoth
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 99.1 S906 Certification
- 99.2 S906 Certification
- 10 Sublicense Agreement
- 10 Stipulated Sum Agreement
- 10 General Conditions of the Contract
- 10 First Amendment to Us License and Co-promotion
- 10 Second Amendment to Flumist Supply Agreement
- 10 Supply of Frozen Product for 2002-03 Flu Season
MEDI similar filings
Filing view
External links
Exhibit 99.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Quarterly Report of MedImmune, Inc. (the "Company") on Form 10-Q for the period ending September 30, 2002 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, David M. Mott, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that: (1) The Report fully complies with the requirements of section 13(a) or 15 (d) of the Securities Exchange Act of 1934; and (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. /s/ David M. Mott - ------------------------------ David M. Mott Chief Executive Officer November 8, 2002